Eris Lifesciences shareholders and shareholding pattern

NSE: ERISBSE: 540596Pharmaceuticals & BiotechnologySmall Cap

Eris Lifesciences Limited · Face value ₹1 · Listed Jun 2017 · Issue price ₹603

₹1,198.40₹93.20 (8.43%)BSE ₹1,197.50

Share price at the NSE close on 27 Oct 2026. Previous close ₹1,105.20.

27 Oct: open ₹1,134.90, high ₹1,215.00, low ₹1,120.40

52-week range of traded prices to 27 Oct 2026

₹1,069.00Low, 26 Oct 2026₹1,740.00High, 9 Dec 2025

Market cap: ₹16,626 Cr353rd largest listed
P/E: 23.50
P/B: 4.01
Dividend yield: 0.60%
ROE: 19.6%
ROCE: 13.4%
Debt to equity: 0.58
Volume, NSE: 7,42,04438.8% delivered

Eris Lifesciences' shareholding pattern for Sep 2026, filed on 19 Oct 2026, with every filing from Jun 2017: who owns its shares by group, its promoters by name and its public holders of 1% or more.

Who owns Eris Lifesciences, filing by filing

Per cent of the company's shares.

Sep 2026 filing

Promoters54.74%
Foreign institutions5.74%
Indian institutions20.20%
GovernmentsNone
Individuals and others19.32%

Shareholding pattern, per cent, from Sep 2022

Promoters
Foreign institutions
Indian institutions
Governments
Individuals and others

Per cent	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
	55.93%	55.93%	55.93%	55.93%	55.93%	55.92%	56.04%	56.10%	56.23%	56.23%	56.23%	55.55%	55.55%	54.08%	54.23%	54.13%	52.69%	52.68%	52.66%	52.66%	52.30%	52.29%	52.70%	52.86%	52.86%	54.91%	54.90%	54.90%	54.88%	54.87%	54.86%	54.85%	54.83%	54.85%	54.85%	53.92%	54.14%	54.74%
Indian promoters	55.93%	55.93%	55.93%	55.93%	55.93%	55.92%	56.04%	56.10%	56.23%	56.23%	56.23%	55.55%	55.55%	54.08%	54.23%	54.13%	52.69%	52.68%	52.66%	52.66%	52.30%	52.29%	52.70%	52.86%	52.86%	54.91%	54.90%	54.90%	54.88%	54.87%	54.86%	54.85%	54.83%	54.85%	54.85%	53.92%	54.14%	54.74%
	44.07%	44.07%	44.07%	44.06%	44.07%	44.08%	43.96%	43.90%	43.77%	43.77%	43.77%	44.45%	44.45%	45.92%	45.77%	45.87%	47.31%	47.32%	47.34%	47.34%	47.70%	47.71%	47.30%	47.14%	47.14%	45.09%	45.10%	45.10%	45.12%	45.13%	45.14%	45.15%	45.17%	45.15%	45.15%	46.08%	45.86%	45.26%
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	15.39%	15.50%	14.86%	13.78%	13.20%	13.14%	14.27%	14.59%	8.01%	8.35%	8.43%	8.40%	7.21%	6.85%	6.39%	5.75%	5.74%
Foreign portfolio investors, category I	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00%	15.50%	14.74%	13.66%	13.10%	13.00%	14.13%	14.44%	7.70%	8.12%	8.11%	7.76%	6.62%	6.33%	6.02%	5.43%	5.41%
Foreign portfolio investors, category II	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	15.39%	0.00%	0.12%	0.12%	0.10%	0.13%	0.14%	0.15%	0.31%	0.24%	0.32%	0.63%	0.59%	0.52%	0.37%	0.33%	0.33%
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	10.68%	9.94%	10.02%	10.74%	14.53%	14.56%	15.63%	16.23%	18.64%	18.06%	18.07%	18.17%	19.36%	20.32%	20.35%	20.72%	20.20%
Mutual funds	8.71%	11.17%	11.44%	10.29%	10.29%	10.69%	10.85%	11.05%	11.12%	12.84%	11.13%	10.51%	10.66%	10.19%	9.63%	9.23%	9.66%	9.57%	9.99%	10.11%	10.36%	10.38%	9.64%	9.64%	10.27%	13.86%	13.85%	14.92%	14.52%	17.03%	16.52%	16.59%	16.78%	17.33%	18.26%	18.22%	18.88%	17.98%
Insurance companies	0.55%	0.60%	0.51%	0.07%	0.05%	0.01%	0.00%	0.00%	0.00%	0.00%	0.01%	0.00%	Under 0.01%	0.15%	0.05%	0.02%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	Under 0.01%	Under 0.01%	Under 0.01%	0.90%	0.92%	0.74%	0.69%	0.64%	1.20%	1.25%	1.31%	1.13%	1.53%
Banks	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%
Alternative investment funds	0.76%	0.45%	0.45%	0.45%	0.45%	0.46%	0.50%	0.59%	0.59%	0.59%	0.66%	0.66%	0.67%	0.56%	0.58%	0.41%	0.39%	0.37%	0.38%	0.40%	0.31%	0.31%	0.31%	0.38%	0.45%	0.66%	0.70%	0.71%	0.81%	0.69%	0.81%	0.79%	0.76%	0.83%	0.80%	0.82%	0.70%	0.68%
Non-bank lenders registered with RBI	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	0.00%	–	–	0.00%	Under 0.01%	Under 0.01%	Under 0.01%
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%
Central government	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	21.64%	21.85%	22.26%	22.63%	17.37%	17.41%	15.19%	14.30%	18.47%	18.72%	18.66%	18.59%	18.57%	17.99%	19.33%	19.40%	19.32%
Resident individuals, up to ₹2 lakh at face value	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.76%	1.95%	2.16%	2.17%	2.29%	2.53%	2.68%	2.47%	2.41%	2.65%	2.53%	2.51%	2.57%	2.62%	2.61%	2.65%	2.50%
Resident individuals, over ₹2 lakh at face value	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	19.50%	19.50%	19.50%	19.90%	13.18%	13.14%	11.56%	11.06%	8.11%	6.64%	6.63%	6.61%	6.55%	5.88%	7.45%	7.45%	7.44%
Companies	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.10%	0.11%	0.29%	0.21%	1.35%	1.35%	0.61%	0.50%	0.42%	0.38%	0.38%	0.34%	0.31%	0.33%	0.27%	0.29%	0.32%
Non-resident Indians	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.19%	0.20%	0.23%	0.24%	0.27%	0.21%	0.22%	0.16%	0.16%	0.18%	0.17%	0.17%	0.17%	0.16%	0.16%	0.16%	0.15%
Foreign companies	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	7.26%	8.79%	8.79%	8.79%	8.78%	8.78%	8.64%	8.63%	8.62%
Directors and their relatives	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	–	–	0.00%	0.00%	0.00%	0.11%
Key managers	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.03%	0.04%	0.04%	0.04%	0.04%	0.05%	0.05%
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.08%	0.09%	0.09%	0.11%	0.28%	0.18%	0.13%	0.11%	0.11%	0.09%	0.11%	0.13%	0.15%	0.16%	0.16%	0.16%	0.13%
Director or Director's Relatives	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	Under 0.01%	Under 0.01%	Under 0.01%	–	–	–	–
Hindu undivided families	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.08%	0.08%	0.09%	0.08%	0.09%	0.08%	0.08%	0.06%	0.07%	0.06%	0.07%	0.08%	0.07%	0.08%	0.08%	0.07%	0.06%
Clearing Members	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.01%	0.01%	Under 0.01%	Under 0.01%	0.17%	0.07%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	0.02%	0.03%	0.03%	0.04%	0.02%
Bodies Corporate	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	Under 0.01%	Under 0.01%	–	–	–	–	0.04%	–	–	–	–	–	–	–	–	–
Trusts	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	Under 0.01%	Under 0.01%	Under 0.01%	–	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	–	–	–	Under 0.01%	Under 0.01%	Under 0.01%
LLP	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	Under 0.01%	–	–	0.02%	0.02%	0.03%	0.04%	–	0.04%	0.03%	0.05%	0.06%	0.05%	0.05%	0.05%	0.05%	0.04%
Independent Director or his relatives	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	Under 0.01%	Under 0.01%	–	Under 0.01%
Promoter shares pledgedShare of the promoters' own shares	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	11.37%	10.95%	10.95%	18.51%	18.51%	18.51%	18.51%	18.51%	16.93%	16.92%	16.92%	16.92%	16.85%	21.25%
Shares in issue	13,75,00,000	13,75,00,000	13,75,00,000	13,75,00,000	13,75,05,486	13,75,15,461	13,75,17,622	13,75,19,783	13,75,19,783	13,75,19,783	13,75,19,783	13,57,80,653	13,57,80,653	13,57,80,653	13,57,80,653	13,57,80,653	13,57,80,653	13,59,08,589	13,59,30,197	13,59,30,197	13,59,72,680	13,59,90,717	13,59,90,717	13,59,92,238	13,59,93,292	13,60,23,248	13,60,28,280	13,60,28,280	13,60,75,008	13,61,05,792	13,61,29,282	13,61,62,569	13,61,97,325	13,62,13,554	13,62,16,891	13,85,42,887	13,85,78,489	13,87,38,569
Shares locked in	12,15,51,250	10,86,25,000	10,86,25,000	10,86,25,000	2,75,00,000	2,75,00,000	2,75,00,000	2,75,00,000	2,75,00,000	2,75,00,000	2,75,00,000	2,75,00,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	–	–	–	23,06,372	23,06,372	23,06,372
Promoters' shares locked in	7,69,04,500	7,69,04,500	7,69,04,500	7,69,04,500	2,75,00,000	2,75,00,000	2,75,00,000	2,75,00,000	2,75,00,000	2,75,00,000	2,75,00,000	2,75,00,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	–	–	–	–	–	–

Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.

Number of Eris Lifesciences shareholders

Shareholders on the company's register in each filing.

Shareholders, filing by filing

Shareholders	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
All shareholders	88,001	53,130	36,841	33,129	31,814	31,959	31,044	29,758	29,567	31,925	33,568	29,195	34,772	42,347	44,521	41,470	46,477	49,833	54,223	57,061	51,639	48,055	46,746	45,931	44,169	42,245	46,496	51,753	44,176	46,346	53,314	50,087	52,225	59,438	54,713	51,656	50,798	49,034
	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	4	4	4	4	4	5	5	5	5	5	5	5	5	5	5	5	5	5
Indian promoters	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	4	4	4	4	4	5	5	5	5	5	5	5	5	5	5	5	5	5
	87,996	53,125	36,836	33,124	31,809	31,954	31,039	29,753	29,562	31,920	33,563	29,190	34,767	42,342	44,516	41,465	46,472	49,828	54,218	57,056	51,635	48,051	46,742	45,927	44,165	42,240	46,491	51,748	44,171	46,341	53,309	50,082	52,220	59,433	54,708	51,651	50,793	49,029
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	104	104	104	95	94	99	112	118	131	134	135	143	138	134	127	126	131
Foreign portfolio investors, category I	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	104	95	89	90	95	107	111	121	124	123	129	124	121	117	116	119
Foreign portfolio investors, category II	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	104	0	9	6	4	4	5	7	10	10	12	14	14	13	10	10	12
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	14	11	11	17	23	27	30	29	36	37	42	49	52	50	53	49	41
Mutual funds	29	32	8	11	12	12	11	11	12	11	12	12	12	11	12	10	11	11	11	11	11	11	8	8	11	12	15	17	15	20	20	22	23	24	24	23	25	18
Insurance companies	4	2	2	1	1	1	0	0	0	0	1	0	1	2	2	2	0	0	0	0	0	0	0	0	1	1	1	2	3	3	3	4	8	9	8	8	7	6
Banks	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Alternative investment funds	4	1	1	1	1	2	2	2	2	2	3	3	3	3	4	3	3	3	3	3	2	2	2	2	4	9	10	9	9	11	12	15	17	18	17	20	15	15
Non-bank lenders registered with RBI	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	0	0	0	1	1	1	1	0	–	–	0	1	1	1
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	0	0	0	0	0	0	1	1	1	1	1	1	1	1
Central government	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	0	0	0	0	0	0	1	1	1	1	1	1	1	1
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	47,933	46,627	45,812	44,053	42,123	46,365	51,606	44,024	46,174	53,137	49,904	52,027	59,242	54,523	51,470	50,617	48,856
Resident individuals, up to ₹2 lakh at face value	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	45,484	44,230	43,393	41,636	39,819	43,955	49,055	41,867	43,935	50,690	47,351	49,365	56,398	51,836	48,803	47,945	46,307
Resident individuals, over ₹2 lakh at face value	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	6	6	6	7	7	7	7	6	6	6	6	6	6	4	5	5	5
Companies	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	166	174	179	194	208	219	229	217	254	276	273	285	275	258	261	263	249
Non-resident Indians	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1,075	1,048	1,074	1,087	1,033	1,067	1,178	927	967	1,138	1,218	1,267	1,411	1,301	1,273	1,268	1,205
Foreign companies	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	0	0	0	0	0	1	1	1	1	1	1	1	1	1
Directors and their relatives	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	0	0	0	0	0	0	0	0	–	–	0	0	0	1
Key managers	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	0	0	0	0	0	0	0	2	2	2	2	2	2	2
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1,202	1,169	1,160	1,129	1,056	1,117	1,137	1,007	1,011	1,026	1,053	1,101	1,149	1,121	1,125	1,133	1,086
Director or Director's Relatives	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1	1	1	–	–	–	–
Hindu undivided families	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1,153	1,136	1,136	1,106	1,037	1,090	1,112	979	974	990	1,015	1,053	1,093	1,059	1,065	1,068	1,035
Clearing Members	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	35	17	11	5	5	6	3	4	8	4	6	5	18	19	18	21	17
Bodies Corporate	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	15	12	–	–	–	–	23	–	–	–	–	–	–	–	–	–
Trusts	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1	1	1	–	1	1	1	1	1	1	1	–	–	–	1	1	2
LLP	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	13	–	–	18	13	20	1	–	28	31	30	42	37	42	40	43	31
Independent Director or his relatives	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1	1	–	1

Eris Lifesciences promoters

Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Amit Indubhusan Bakshi, 42.96%. The filing names 56 more members with no shares.Promoter buying and selling

Holder
Amit Indubhusan BakshiIndividuals and Hindu undivided families	42.96%	5,95,96,636	19.59%
Inderjeet Singh NegiIndividuals and Hindu undivided families	4.28%	59,39,833	31.69%
Rajendrakumar Rambhai PatelIndividuals and Hindu undivided families	4.28%	59,39,834	31.69%
Kaushal Kamleshkumar ShahIndividuals and Hindu undivided families	3.22%	44,68,833	15.66%
Sarthak NegiIndividuals and Hindu undivided families	0.00%	100	0.00%

Pledged is the share of the holder's own shares pledged to a lender.

Largest public holders of Eris Lifesciences, filing by filing

Per cent, on the same shares as the split above.Mutual funds holding Eris Lifesciences

Holder	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Lilac Investments LimitedForeign companies	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	7.26%	8.79%	8.79%	8.79%	8.78%	8.78%	8.64%	8.63%	8.62%
Hetal Rasiklal ShahResident individuals, over ₹2 lakh at face value	3.50%	3.50%	3.50%	3.50%	3.50%	3.50%	3.50%	3.50%	3.48%	3.48%	2.97%	2.97%	2.96%	2.89%	2.85%	2.81%	2.72%	2.69%	2.69%	2.69%	2.68%	2.68%	2.68%	2.68%	2.68%	2.62%	2.58%	2.58%	2.40%	2.20%	2.20%	2.20%	2.18%	2.16%	2.16%	2.12%	2.12%	2.12%
Bhikhalal Chimanlal ShahResident individuals, over ₹2 lakh at face value	8.04%	8.04%	8.04%	8.04%	8.04%	7.76%	7.76%	7.76%	7.76%	7.76%	6.60%	6.55%	6.55%	6.55%	6.55%	6.55%	6.53%	6.53%	6.52%	6.52%	4.32%	4.32%	4.32%	4.32%	4.31%	4.30%	4.30%	2.76%	2.76%	1.97%	1.97%	1.97%	1.97%	1.97%	1.97%	1.93%	1.93%	1.93%
Naishadh Vikram ShahResident individuals, over ₹2 lakh at face value	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.66%	1.66%	1.66%
Rakesh ShahResident individuals, over ₹2 lakh at face value	–	–	–	11.53%	11.53%	11.53%	11.53%	11.53%	11.53%	11.53%	11.53%	11.55%	11.55%	11.55%	11.55%	11.55%	11.55%	11.54%	11.54%	11.54%	11.53%	11.53%	11.53%	11.53%	11.53%	4.88%	4.88%	4.88%	4.88%	2.92%	1.45%	1.45%	1.45%	1.45%	1.45%	1.43%	1.43%	1.42%
Emerald Investments LimitedForeign portfolio investors, category I	–	–	–	–	–	–	–	–	–	–	2.60%	5.51%	5.51%	5.51%	5.51%	5.51%	5.51%	5.50%	5.50%	5.50%	7.58%	7.58%	7.58%	7.58%	7.58%	7.58%	7.58%	7.27%	7.27%	–	–	–	–	–	–	–	–	–
Plutus Wealth Management LlpCompanies	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.10%	1.10%	–	–	–	–	–	–	–	–	–	–	–
Kuwait Investment Authority Fund 225Foreign portfolio investors, category I	–	–	–	–	–	–	–	–	–	–	–	–	–	1.11%	1.11%	–	–	–	–	–	–	–	1.47%	1.47%	1.47%	1.10%	1.03%	–	–	–	–	–	–	–	–	–	–	–
UTI India Dynamic Equity FundForeign portfolio investors, category II	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.06%	1.00%	–	1.02%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Fundsmith Emerging Equities Trust PlcInstitutions Foreign Portfolio Investor	–	–	–	–	–	–	–	–	1.11%	1.11%	1.11%	1.09%	1.09%	1.09%	1.09%	1.09%	1.09%	1.09%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Abu Dhabi Investment Authority - BehaveInstitutions Foreign Portfolio Investor	–	1.01%	1.01%	1.01%	1.01%	1.01%	1.01%	1.01%	1.01%	1.01%	1.01%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Matthews India FundInstitutions Foreign Portfolio Investor	–	–	–	1.02%	1.42%	1.42%	1.42%	1.42%	1.15%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Goldman Sachs India LimitedInstitutions Foreign Portfolio Investor	1.99%	1.65%	1.65%	1.37%	1.31%	1.20%	1.20%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Rakeshbhai Bhikhabhai ShahResident individuals, over ₹2 lakh at face value	11.53%	11.53%	11.53%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Merrill Lynch Markets Singapore Pte. LtdInstitutions Foreign Portfolio Investor	1.15%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.

Who moved in the Sep 2026 filing

Against the Jun 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.

Individuals and others: Lilac Investments Limited 8.62%, −0.01 pts; Rakesh Shah 1.42%, −0.01 pts